BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 6184512)

  • 1. [Immunochemical analysis of prostatic acid phosphatase. 2. Evaluation of normal individuals and patients with prostatic hypertrophy and a comparison with conventional methods].
    Sakai S; Kato N; Setsuda O; Tei K; Kawada Y; Nishiura T; Sawada H
    Nihon Hinyokika Gakkai Zasshi; 1982 May; 73(5):599-608. PubMed ID: 6184512
    [No Abstract]   [Full Text] [Related]  

  • 2. [Immunochemical analysis of prostatic acid phosphatase. 3. Evaluation of patients with prostatic cancers and cancer of other organs and a comparison with conventional method].
    Sakai S; Kato N; Shimazu R; Doi T; Shimizu Y; Kawada Y; Nishiura T; Sawada H
    Nihon Hinyokika Gakkai Zasshi; 1982 May; 73(5):609-18. PubMed ID: 6184513
    [No Abstract]   [Full Text] [Related]  

  • 3. [Detection of prostatic acid phosphatase by an immunochemical method. 4. Comparison with radioimmunoassay].
    Sakai S; Kato N; Ishiyama S; Fujimoto Y; Deguchi T; Muranaka K; Setsuda O; Kuriyama M; Kawada Y; Nishiura T
    Nihon Hinyokika Gakkai Zasshi; 1983 Jun; 74(6):945-55. PubMed ID: 6197550
    [No Abstract]   [Full Text] [Related]  

  • 4. [Clinical evaluation of serum prostatic acid phosphatase assay based on the immunoenzymatic method (TZR-516)].
    Ikemoto I; Machida T; Oishi Y; Onishi T; Shirai T; Imanaka K
    Hinyokika Kiyo; 1989 Sep; 35(9):1639-42. PubMed ID: 2479240
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of prostatic massage on acid phosphatase in patients with and without benign prostatic hypertrophy.
    Glazener CM; Pringle R
    Br J Clin Pract; 1982 Sep; 36(9):305-6. PubMed ID: 6185127
    [No Abstract]   [Full Text] [Related]  

  • 6. [Total and tartrate-inhibited acid phosphatases in serum. Significance of rectal examination in normal individuals and patients with benign prostatic hypertrophy].
    Nielsen ML; Christensen P; Antoni E
    Ugeskr Laeger; 1971 Nov; 133(46):2279-84. PubMed ID: 4109415
    [No Abstract]   [Full Text] [Related]  

  • 7. [Role of prostatic acid phosphatases in the treatment of adenocarcinoma of the prostate].
    Perrin P; Clairet F; Fleury-Goyon MC; Durand L
    J Urol (Paris); 1984; 90(1):19-22. PubMed ID: 6202800
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Critical study of acid phosphatases in benign prostatic hypertrophy].
    Rodrigues Netto Júnior N; de Andrade AC; Lemos GC; de Araujo JT
    AMB Rev Assoc Med Bras; 1982; 28(3-4):93-5. PubMed ID: 6189151
    [No Abstract]   [Full Text] [Related]  

  • 9. [Studies on prostatic phosphatase. II. Study on serum acid phosphatase].
    Nakano S
    Hinyokika Kiyo; 1969 Aug; 15(8):565-75. PubMed ID: 4186705
    [No Abstract]   [Full Text] [Related]  

  • 10. Prostatic acid phosphatase and prostate-specific antigen in prostate cancer.
    Kuriyama M; Loor R; Wang MC; Lee C; Killian CS; Papsidero LD; Inaji H; Nishiura T; Slack NH; Murphy GP; Chu TM
    Int Adv Surg Oncol; 1982; 5():29-49. PubMed ID: 6178696
    [No Abstract]   [Full Text] [Related]  

  • 11. [Enzymological study of prostatic cancer VIII. Comparison of acid phosphatase by measurement of enzymatic level and radioimmunoassay in diagnosis of patients with prostatic carcinoma (author's transl)].
    Ishibe T
    Nihon Hinyokika Gakkai Zasshi; 1980 Dec; 71(12):1484-8. PubMed ID: 6164809
    [No Abstract]   [Full Text] [Related]  

  • 12. [Determination of activity of acid phosphatase in serum in prostatic diseases].
    Ianishevskaia AD
    Lab Delo; 1967; 5():277-80. PubMed ID: 4184710
    [No Abstract]   [Full Text] [Related]  

  • 13. Enzyme markers in human prostatic carcinoma.
    Chu TM; Wang MC; Kuciel R; Valenzuela L; Murphy GP
    Cancer Treat Rep; 1977; 61(2):193-200. PubMed ID: 68822
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinical evaluation and measurement of plasma prostatic acid phosphatase by solid phase enzyme immunoassay].
    Okabe H; Noma A; Nakauchi K; Mori M
    Rinsho Byori; 1986 Jul; 34(7):805-10. PubMed ID: 2428995
    [No Abstract]   [Full Text] [Related]  

  • 15. [Prostatic acid phosphatase measured by immunoenzyme assay].
    Fuse H; Zama S; Shimazaki J
    Hinyokika Kiyo; 1985 Nov; 31(11):1957-64. PubMed ID: 2418660
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Changes in acid phosphatase levels during various prostatic operations].
    Vitsou-Georgallis H; Goulandris N; Marketos N; Dimopoulos C
    Acta Urol Belg; 1980 Oct; 48(4):488-97. PubMed ID: 6161530
    [No Abstract]   [Full Text] [Related]  

  • 17. Comparison of prostatic acid phosphatase assays.
    Wise WS; Kandaswamy K
    Arch Pathol Lab Med; 1981 Nov; 105(11):622-5. PubMed ID: 6170271
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ratio of serum tartrate-inhibitable acid phosphatase to total serum protein in benign prostatic hypertrophy and prostatic carcinoma.
    Petrovich G; Ursich-Jankovich J; Prijovich Z
    Clin Chem; 1992 Feb; 38(2):276-7. PubMed ID: 1371723
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Value of commercial enzyme immunoassays in the determination of prostatic acid phosphatase].
    Rassweiler J; Lutz K; Müller HA; Eisenberger F
    Urologe A; 1988 Jan; 27(1):32-5. PubMed ID: 2452506
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Serum acid phosphatase activity in pathology].
    Paget M; Sanchez E; Vanneste A; Coustenoble P
    J Sci Med Lille; 1972; 90(8):283-94. PubMed ID: 4118620
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.